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Columbia, CanadaABSTRACT Previous studies on aurein 2.2 and 2.3 in DMPC/DMPG and POPC/POPG membranes have shown that bilayer
thickness and phosphatidylglycerol content have a significant impact on the interaction of these peptides with membrane bila-
yers. Further examination with the DiSC35 assay has indicated that aurein 2.2 induces greater membrane leakage than aurein
2.3 in Staphylococcus aureus C622. The only difference between these peptides is a Leu to Ile mutation at residue 13. To better
understand the importance of this residue, the structure and activity of the L13A, L13F, and L13V mutants were investigated.
In addition, we investigated a number of peptides with truncations at the C-terminus to determine whether the C-terminus, which
contains residue 13, is crucial for antimicrobial activity. Solution circular dichroism results demonstrated that the L13F mutation
and the truncation of the C-terminus by six residues resulted in decreased helical content, whereas the L13A or L13V mutation
and the truncation of the C-terminus by three residues showed little to no effect on the structure. Oriented circular dichroism
results demonstrated that only an extensive C-terminal truncation reduced the ability of the peptide to insert into lipid bilayers.
31P NMR spectroscopy showed that all peptides disorder the headgroups. The implications of these results in terms of antimi-
crobial activity and the ability of these peptides to induce leakage in S. aureus are discussed. The results suggest that the pres-
ence of the 13th residue in aurein 2.2 is important for structure and activity, but the exact nature of residue 13 is less important as
long as it is a hydrophobic residue.INTRODUCTIONCationic antimicrobial peptides are an important class of
peptides that are ubiquitous in nature and form an important
part of the immune defense system of many plants and
animals. Their unique property of displaying little or no
intrinsic or mutational resistance (1–3) has led to wide
interest in exploring them as alternatives to currently used
antibiotics. Examples include a range of cationic antimicro-
bial peptides secreted by amphibians as part of their host-
defense mechanisms (4,5). When these animals are exposed
to various stresses or stimuli, they secrete a wide range of
host-defense compounds, including amines, alkaloids, and
peptides (4). Many studies have reviewed (4–6) or exten-
sively characterized these peptides, including magainin
(7–16), maculatin (17–22), and brevinins (23–28), and
others, such as citropin 1.1 and aurein 1.2, from the
Australian tree frogs Litoria citropa and Litoria aurea
(17–20,22,29–31), respectively. The latter peptide is part
of a larger family of peptides known as the aurein peptides,
which range in length from 13 to 25 residues. Many aurein
peptides carry an amidated C-terminus and exhibit broad-
spectrum antimicrobial activity against Gram-positive
bacteria and other disease-causing agents, such as cancerous
cells (30).
Previous works examined the structure-function relation-
ships of two members of the aurein peptide family, aureinSubmitted June 11, 2010, and accepted for publication August 30, 2010.
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0006-3495/10/11/2926/10 $2.002.2 (GLFDIVKKVVGALGSL-CONH2) and aurein 2.3
(GLFDIVKKVVGAIGSL-CONH2), as well as an inactive
version of aurein 2.3 with a carboxy C-terminus (aurein
2.3-COOH) (32,33). Results from solution circular
dichroism (CD) and oriented CD (OCD), solid-state
31P NMR, calcein release assays, and differential scanning
calorimetry experiments using DMPC/DMPG and POPC/
POPG membranes demonstrated that the bilayer thickness
and phosphatidylglycerol content have a significant impact
on the behavior of these aurein peptides in different
membrane environments (33). The model that emerged
from these studies is that all three peptides cause significant
membrane perturbations in DMPC/DMPG, leading to the
formation of micelles. In POPC/POPG, on the other hand,
all three peptides form (disordered) toroidal pores, with
little leakage. Some of the data indicate that the observed
membrane perturbation is dependent on the amino acid
sequence. For instance, peptide-membrane interactions are
concentration-dependent and differ among aurein 2.2,
aurein 2.3, and aurein 2.3-COOH. Results from 3,30-dipro-
pylthiadicarbocyanine iodide (DiSC35) assays, which
measure the ability of peptides to dissipate the membrane
potential gradient, have indicated that aurein 2.2 induces
greater membrane leakage than aurein 2.3 in intact Staphy-
lococcus aureus C622 cells. Given that aurein 2.2 and 2.3
have similar minimal inhibitory concentrations (MICs)
(32), the difference in the ability of the peptide to perturb
membranes indicates that aurein 2.2 and 2.3 may kill
Gram-positive bacteria via somewhat different mechanisms.doi: 10.1016/j.bpj.2010.08.077
Mutant Aurein 2.2 Structure/Function 2927To elucidate the mechanism of action of aurein 2.2 and
aurein 2.3, and to better understand how a subtle difference
in sequence at residue 13 might affect the mode of action,
we investigated peptides with mutations at position 13 and
peptides with C-terminal truncations. Although a large
number of peptides would be needed for a complete and
comprehensive study, we were able to use prior information
about the effect of mutations on other peptides (34–38) and
limit our focus to five peptides. The first three peptides
consisted of a single conservative mutation at residue 13
from one hydrophobic residue (L) to another. The peptides
with L13A, L13F, and L13V were chosen specifically to
probe the effect of steric hindrance (L13A mutation),
aromatic ring-lipid interaction (L13F mutation), and hydro-
phobicity (L13V mutation) on structure and activity. The
last two peptides consisted of the native aurein 2.2 sequence,
with the last three (aurein 2.2-D3) or six residues missing
(aurein 2.2-D6). In aurein 2.2-D3, residue 13 became the
last residue in sequence, and in aurein 2.2-D6, residue 13
was completely removed. Since most of the peptides in
the aurein family have conserved N-termini, we anticipated
that a modest C-terminal truncation would have little effect
on activity.
To determine the mode of action of the five peptides
mentioned above, we determined their structure and
activities. Solution CD spectroscopy was used to examine
whether these peptides have different a-helical content in
the membrane environment. To assess how these mutants
interact with the lipid bilayers, we used OCD and 31P NMR
spectroscopy. DiSC35 assays (using S. aureus C622) were
performed to examine whether changes in sequence affect
the ability of peptides to disrupt intact cell bacterial
membranes. Finally, theMIC of each peptidewas determined
against S. aureus strain C622 and Staphylococcus epidermi-
dis strain C621 to correlate observations made in model
membranes to the behavior of these aurein peptides in the
presence of intact bacteria. Overall, these data allowed us
to determine the role of specific residues in structure and
activity, and to better understand how sequence variation
modulates structure-function relationships.MATERIALS AND METHODS
Materials
Details pertaining to the materials used in this study can be found in the
Supporting Material.Methods
Peptide synthesis and purification
Aurein 2.2 mutants (Table S1) were synthesized as previously described
(32) using a peptide synthesizer (CS Bio Co., Menlo Park, CA) and
in situ neutralization Fmoc chemistry. All peptides were C-terminally ami-
dated. The crude peptide product was purified by preparative reverse-phase
high-performance liquid chromatography on a Waters 600 system (WatersLimited, Mississauga, Ontario, Canada) as previously described (32,33).
The identity of the products was verified and confirmed to be R99%
pure. The molecular weights of the five aurein mutant peptides in this study
(as well as aurein 2.3) can be found in Table S1.
Circular dichroism
Solution and oriented CD experiments were carried out using a J-810 spec-
tropolarimeter (JASCO, Victoria, British Columbia, Canada) at 30C as
previously described (32) (see Supporting Material for sample preparation
and further details).
NMR spectroscopy
Solid-state 31P NMR experiments on mechanically aligned lipid bilayer
samples were carried out on a Bruker 500-MHz NMR spectrometer (Mil-
ton, Ontario, Canada) at 30C, operating at a phosphorus frequency of
202.40 MHz as previously reported (32). The 90 pulse was set to
11.25 ms (POPC/POPG) and a 3 s recycle delay was used. The spectra
were acquired using 2048 scans and processed with 50 Hz line-broadening.
MIC determination
The MICs for L13A, L13F, L13V, aurein 2.2-D3, and aurein 2.2-D6 were
determined based on a previously described methodology with modifica-
tions (39) (see the Supporting Material for more details).
DiSC35 assay
The ability of the aurein peptides to depolarize the cytoplasmic membrane
of S. aureus C622 was determined using the membrane potential-sensitive
dye 3,30- dipropylthiadicarbocyanine iodide (DiSC35). C622 was grown to
mid-logarithmic phase in LB media, centrifuged, washed in 5 mM HEPES
and 20 mM glucose, and then resuspended in the same buffer to a final
OD600 of 0.05. A final concentration of 200 mM KCl was added to the cells
and left for 30 min at room temperature to equilibrate cytoplasmic and
external Kþ concentrations before the DiSC35 was added at a final concen-
tration of 0.8 mM for 30 min (see the Supporting Material for more details).RESULTS
Secondary structure of the aurein mutants
Our previous studies (33) suggested that 1:1 POPC/POPG
(mol/mol) membranes might be the most representative
model for investigating the interaction of aurein peptides
with Gram-positive bacteria. As presented in a recently
submitted manuscript (J. T. J. Cheng, J. D. Hale, J. Kindra-
chuk, H. Jessen, M. Elliott, R. E. W. Hancock, and S. K.
Straus), we explored this further by investigating the struc-
ture and membrane interaction of the five mutants studied
here in 1:1 POPE/POPG (mol/mol) membranes and 1:1
cardiolipin/POPG (mol/mol) membranes. We found that
both POPC/POPG and cardiolipin/POPG are good models
for Gram-positive bacteria like S. aureus and S. epidermidis.
Since these are the bacteria of interest in this study, we will
therefore focus exclusively on the results obtained in 1:1
POPC/POPG.
The solution CD spectra of the five aurein mutants in 1:1
POPC/POPG (mol/mol) small unilamellar vesicles (SUVs)
were recorded (Fig. S1). All spectra demonstrated
a maximum at 190 nm and two minima at 207 nm and
222 nm, which are characteristic of a-helical structure.Biophysical Journal 99(9) 2926–2935
2928 Cheng et al.This demonstrated that all five aurein mutants adopted an
a-helical conformation in POPC/POPGSUVs.As previously
observed (32), similar intensities were found for all peptide/
lipid molar ratios (P/L ¼ 1:15, 1:50, and 1:100) studied,
indicating that maximum binding of the peptide to the lipid
vesicles occurred (20). The CD data were then fitted using
three different programs (CDSSTR (41), CONTINLL (42),
and SELCON3 (43–45)) to determine secondary structure
content under all conditions probed here. Fig. 1 shows the
percentage ofa-helical and random coil content as a function
of P/L ratios for the five aureinmutants. The results show that
all five aurein mutants adopted a close to 100% a-helical
conformation at high P/L ratios. As previously observed
(33), helical content increased with increasing peptide
concentrations, indicating that high concentrations are
needed to achieve maximum folding. At lower peptide
concentrations, however, differences in helical content
were observed. At a 1:50 P/L ratio, L13A, L13V, and aurein
2.2-D3 showed higher helical content (96 ~ 98%), whereas
L13F and aurein 2.2-D6 showed lower helical content (53 ~
66%). Overall, the data show that the structures of the five
aurein mutants were retained but the structural content was
dependent on the molar concentrations examined, and differ-
ences were significant at lower peptide concentrations.Membrane insertion states of the mutant aurein
peptides
Understanding the interaction of aurein mutants with model
membranes is crucial for elucidating the effect of peptide
modification on the extent of peptide insertion into the lipidFIGURE 1 Secondary structure content of the five aurein mutants in 1:1
POPC/POPG (mol/mol) SUVs: the percentage of a-helical content and
random coil content were plotted as a function of P/L ratios and aurein
mutants (as indicated).
Biophysical Journal 99(9) 2926–2935bilayers. We conducted OCD experiments to investigate the
peptide insertion profiles in 1:1 POPC/POPG (mol/mol)
bilayers. For both OCD and solid-state 31P NMR (see
following section), the samples were prepared in a similar
fashion so that the data sets could be directly compared
and also to verify that the samples were aligned. All exper-
iments were conducted at 30C (liquid crystalline phase) for
consistent comparison with our previous study. In addition,
experiments were repeated at least twice to ensure reproduc-
ibility of the results.
Fig. 2 shows OCD results for the aurein mutants in 1:1
POPC/POPG (mol/mol) bilayers as a function of P/L ratios.
The spectra were normalized such that the intensities of all
the spectra at 222 nm are the same. The spectra (Fig. 2, b–d)
show that L13F, L13V, and aurein 2.2-D3 mutants inserted
(inserted (I-state) or tilt (T-state)) into POPC/POPG bilayers
at threshold P/L molar ratios between 1:80 and 1:120, and
were surface adsorbed (S-state) at P/L ratios > 1:120
(mol/mol). L13A showed less insertion at the 1:80 P/L ratio
and a more gradual insertion profile (Fig. 2 a and Fig. S2).
Aurein 2.2-D6, on the other hand, inserted into POPC/POPG
bilayers (Fig. 2 e) only at higher peptide concentrations,
with a threshold P/L ratio between 1:15 and 1:80. The
data illustrate that changing L13 to Phe or Val or removing
the last three residues of aurein 2.2 did not change the inser-
tion profile of the peptides, as the parent aurein 2.2 also
showed a threshold P/L molar ratio between 1:80 and
1:120 (33). Changing L13 to Ala, however, shifted the inser-
tion profile (Fig. S2) more toward that of aurein 2.3, which
displayed a threshold P/L ratio between 1:40 and 1:30 (33).
Finally, complete removal of L13 by means of the six-
residue truncation drastically perturbed the insertion profile
of the peptide, making the peptide behave more like aurein
2.3-COOH (33). Overall, this suggests that either removing
the long hydrophobic leucine (in the case of aurein 2.2-D6)
or shortening the side chain (as in L13A) reduced the ability
of the peptide to anchor into POPC/POPG membranes. This
suggests that residues 11–13 may play an important role in
aurein peptide insertion into lipid bilayers.Lipid headgroup perturbation
31P NMR spectra were recorded for all peptides in 4:1
POPC/POPG (mol/mol) (Figs. 3 and 4) bilayers, as in our
previous studies (33). 31P NMR experiments were con-
ducted to determine whether the insertion of the peptides
was accompanied by a perturbation of the lipid headgroups,
and whether this membrane disruption occurred via a barrel-
stave model, carpet model, or toroidal pore model (16,46–
49); a micellar aggregate channel model (50,51); or a deter-
gent-like mechanism (52).
In the absence of aurein mutants, the spectra consisted
primarily of two single resonances at 30 ppm and 15 ppm
(relative ratio of integral of peak at 30 ppm to the one at
15 ppm is 4:1, as determined using DMFIT (53) (not
FIGURE 2 Oriented CD spectra of aurein
mutants in 1:1 POPC/POPG (mol/mol) bilayers:
(a) L13A, (b) L13F, (c) L13V, (d) aurein 2.2-D3,
and (e) aurein 2.2-D6. The P/L molar ratios are
1:15 (blue), 1:80 (red), and 1:120 (green).
Mutant Aurein 2.2 Structure/Function 2929shown)), which indicates that the lipid bilayers were aligned
with their normal parallel to the magnetic field (Figs. 3 and
4). We attribute the resonance at 30 ppm as belonging to
POPC, and that at 15 ppm as belonging to POPG, given
the integrals observed. This would imply that compared to
the spectra shown in our previous study (33), the 31P spectra
were better resolved. This may be related to an improved
alignment achieved by incubating the samples for 8 rather
than 7 days, drying the lipids under a stream of N2 rather
than air, and resuspending the lipids in a slightly larger
volume of water before depositing them on the slides.
However, it is possible that the resonances at 30 and
15 ppm are simply due to different populations of lipids in
the samples, with one being more mobile that the other.
In the presence of the aurein mutants, the spectra showed
slightly broadened peaks at 30 and 15 ppm, indicating an
increased contribution from the unaligned 31P headgroups.
In addition, a powder-pattern signal was also observed in
the 10 to 30 ppm region, indicative of random headgroup
orientations (Figs. 3 and 4). In general, as the concentration
of the peptides increased, the contribution of the powder
pattern signal became more dominant, as seen in Figs. 3 d
and 4 d (see figure caption for proportion of unaligned signal
(54,55)). For the mutants L13A, L13F, and aurein 2.2-D3,the line at 30 ppm remained relatively sharp, even at high
peptide concentrations (P/L ¼ 1:15), suggesting that
a significant proportion of the sample was still reasonably
well aligned, i.e., that the lipids formed bilayers. For aurein
2.2-D6 (Fig. 4, right), however, the degree of lipid head-
group perturbation was more significant, as evidenced by
the more intense powder pattern. Finally, for POPC/POPG
in the presence of L13V at high concentrations (Fig. 3,
right), the peak at 30 ppm was broadened substantially
and the powder pattern increased significantly at a P/L ratio
of 1:15. This suggests that L13V may be more disruptive to
the bilayer headgroup alignment than any of the other
mutants at high concentrations.
A comparison of the 31P spectra at P/L ratios where the
peptides were inserted (based on the OCD findings) suggests
that all of the peptides perturbed the bilayers to a similar
extent. The underlying powder pattern indicates that the
aurein mutants might disorder the bilayer headgroups by
the formation of (distorted) toroidal pores (16,46–49).Antimicrobial activity
Given that all of the five aurein mutants studied here
primarily adopt a-helical structures but interact with theBiophysical Journal 99(9) 2926–2935
FIGURE 3 Solid-state 31P NMR spectra of me-
chanically aligned 4:1 POPC/POPG (mol/mol)
bilayers containing the three residue 13 aurein
mutants: (a) POPC/POPG bilayers alone, P/L ¼
(b) 1:120, (c) 1:80, and (d) 1:15 in the presence
of L13A (left panel), L13F (center panel), and
L13V (right panel). At P/L ratios of 1:15, the
proportion of unaligned lipids increases by 34%
for L13A, 23% for L13F, and 41% for L13V. These
percentages are determined by fitting the spectra in
Fig. 3 using two Gaussian/Lorentzian lines and one
31P CSA static line in DMFIT (53) and integrating.
2930 Cheng et al.membranes differently, we determined the MICs of all five
aurein mutants against two Gram-positive bacteria
(S. aureus and S. epidermidis). The MICs, reported in
Table 1, indicate that the L13F, L13V, and L13A mutants
have activities very similar to those of the parent peptide,
aurein 2.2 (32), under the conditions used here. These
mutants had identical MICs of 16 mg/mL against the wild-
type S. aureus strain C622. Aurein 2.2-D3 still showed
considerable activity (MIC ¼ 32 mg/mL), whereas aurein
2.2-D6 was inactive, with an MIC of 128 mg/mL (4,31).
However, the MICs of the L13A, L13F, and L13V mutants
against the wild-type S. epidermidis strain C621 were
slightly different. L13A and L13V showed similar MICs
of 8 mg/mL, as did aurein 2.2, whereas L13F had a slightly
lower MIC of 16 mg/mL. Likewise, the MICs of the C-termi-
nally truncated mutants were different. Aurein 2.2-D3 had
an MIC identical to that of the L13A and L13V mutants
(8 mg/mL), whereas aurein 2.2-D6 again showed no activity,
with an MIC of 128 mg/mL. Wells containing polymyxin B,
aurein 2.2, culture only, and broth only were used as
controls. The MICs observed for polymyxin B and aurein
2.2 are reported in Table 1 and agree with literature findings
(32,56). The MICs for all the peptides against the Gram-
negative bacteria Escherichia coli (MICs R 32 mg/mL)
support the finding that the aurein peptides are more active
against Gram-positive bacteria (57).Bacterial membrane leakage induced
by the aurein mutants
Antimicrobial peptides can kill bacteria through many
different mechanisms, one of the most common of whichBiophysical Journal 99(9) 2926–2935is cytoplasmic membrane depolarization. To observe the
effects aurein mutants had on the cytoplasmic membrane
of S. aureus C622, we carried out membrane depolarization
experiments using the membrane-sensitive dye DiSC35.
This fluorescent dye is a caged cation that concentrates in
the cytoplasmic membrane according to the membrane
potential and self-quenches. Destruction of the ionic barrier
function of the membrane causes membrane depolarization,
release of DiSC35, and a consequent increase (dequenching)
of fluorescence. All peptides were compared with the
membrane-acting cyclic peptide Gramicidin S. Fig. 5 a
shows that at 1MIC, both L13F and aurein 2.2-D3 demon-
strated greater membrane depolarization than any of the
other peptides. L13A and L13V both showed a similar
extent of depolarization, whereas aurein 2.2-D6 was much
less efficient than any other peptide. Fig. 5 c illustrates the
percentage of membrane depolarization with respect to
Gramicidin S at 300 s after peptide addition. The efficiency
of membrane depolarization of the five aurein mutants in
increasing order was as follows: aurein 2.2-D6, L13A/
L13V, and L13F/aurein 2.2-D3. Increasing the level of aur-
ein peptide added to 5MIC (Fig. 5 b) showed an increased
depolarization effect for L13A and aurein 2.2-D6, but not
for the other mutants (Fig. 5 d). This suggests that most
mutants, with the exceptions of L13A and aurein 2.2-D6,
are already at their maximum depolarization efficiency at
1 MIC.DISCUSSION
Determining which residue is crucial to antimicrobial
activity can be a key step in understanding the mechanism
FIGURE 4 Solid-state 31P NMR spectra of mechanically aligned 4:1
POPC/POPG (mol/mol) bilayers containing the two C-terminally truncated
aurein mutants: (a) POPC/POPG bilayers alone, P/L ¼ (b) 1:120, (c) 1:80,
and (d) 1:15 in the presence of aurein 2.2-D3 (left panel) and aurein 2.2-D6
(right panel). At P/L ratios of 1:15, the proportion of unaligned lipids
increases by 13% for aurein 2.2-D3 and 50% for aurein 2.2-D6. These
percentages are determined by fitting the spectra in Fig. 4 using two
Gaussian/Lorentzian lines and one 31P CSA static line in DMFIT (53)
and integrating.
Mutant Aurein 2.2 Structure/Function 2931of action of a given antimicrobial peptide. In this study we
investigated five mutant peptides from aurein 2.2, an antimi-
crobial peptide from the Australian Southern Bell frog
L. aurea, to examine how residue-13 substitutions and
C-terminal truncations affect structure, membrane interac-
tion, and activity.
Our previous studies demonstrated that aurein 2.2 and
aurein 2.3 showed similar antimicrobial activity (32) butTABLE 1 MICs (in mg/mL) of the five aurein mutants, aurein 2.2, an
Peptide Sequence
Aurein 2.2-CONH2 GLFDIVKKVVGALGSL
L13A-CONH2 GLFDIVKKVVGAAGSL
L13F-CONH2 GLFDIVKKVVGAFGSL
L13V-CONH2 GLFDIVKKVVGAVGSL
Aurein 2.2-D3-CONH2 GLFDIVKKVVGAL
Aurein 2.2-D6-CONH2 GLFDIVKKVV
Polymyxin B
MICs are given as the most frequently observed value obtained from repeat exp
dated.perturbed membranes to a different extent (33). Aurein 2.2
and aurein 2.3 differ by only one residue at position 13.
Residue specificity at this position may therefore be a key
to the difference in the peptide-lipid interactions. When
examining a specific residue, one must consider several
factors. First, steric hindrance usually plays an important
role in peptide/protein activities or folding patterns
(58–63). Second, aromatic residues, especially tryptophan,
have been shown to promote peptide insertion into the lipid
bilayers (34,64). Lastly, hydrophobicity is widely accepted
as a key factor in achieving high antimicrobial activity
(65,66). Here, we substituted Leu-13 with Ala-13 to test
the effect of steric hindrance, Phe-13 to test the importance
of aromatic residues, and Val-13 to test the effect of hydro-
phobic chain length on the structure-function relationship of
the aurein 2 family peptides.
Our solution CD results showed that the three aurein
mutants L13A, L13F, and L13V adopted a-helical structure
in the presence of 1:1 POPC/POPG membranes. Several
studies have also demonstrated that mutated antimicrobial
peptides adopt similar structures (e.g., human b defensin-
1, bacteriocin, and dermcidin (67–70)), similar structures
but with varying structural content (e.g., mesentericin
Y105 and MSI-78/LL37 analogs (65,71)), or entirely
different conformations (e.g., truncated human b defensin-
3 (72)). The extent of the change in structure depends on
the nature and position of the amino acid that is substituted.
We showed here that for relatively conservative substitu-
tions of the aurein peptides, the structures were preserved
but the helical contents of the three mutants were different,
particularly at low peptide concentrations. This indicates
that secondary structure is dependent on the nature of the
amino acid at residue 13, in similarity to previous findings
from a mesentericin Y105 mutant (71). When we compared
the helical content at a P/L ratio of 1:100, we found that
L13V was the most helical, followed by aurein 2.2 and
aurein 2.3, then L13A, and finally L13F. This trend does
not parallel the hydrophobicity trend in the Kyte and Doolit-
tle scale (73), where Ile is more hydrophobic than Val,
followed by Leu, Phe, and finally Ala, or in any other
available hydrophobicity scale (74,75). This indicates thatd polymyxin B toward S. aureus and S. epidermidis
MIC (mg/mL)
S. aureus
(C622)
MIC (mg/mL)
S. epidermidis
(C621)
MIC (mg/mL)
E. coli
(UB1005)
16 8 64
16 8 64
16 16 64
16 8 64
32 8 32
128 128 128
50 55
eriments. Note that all the peptides used in this study are C-terminally ami-
Biophysical Journal 99(9) 2926–2935
FIGURE 5 Membrane depolarization of
S. aureus C622 induced by the aurein mutants at
1 and 5 MIC. Gramicidin S (1 MIC) was
used as a control. Results are representative of
three repeats. (a and b) DiSC35 release profile of
aurein mutants as a function of time at (a) 1
and (b) 5MIC. (c) Percent membrane depolariza-
tion induced by aurein mutants at 300 s after
peptide addition with respect to Gramicidin S as
the control. (d) Membrane depolarization effi-
ciency at 300 s after peptide addition at 5 MIC
relative to 1 MIC.
2932 Cheng et al.hydrophobicity alone cannot account for structural differ-
ences, and that other factors, such as the side chain’s bulk-
iness and its ability to interact with neighboring residues,
must play a structural role.
Hydrophobicity alone does not account for how the
peptides interacted with POPC/POPG membranes either.
The OCD results suggest that L13F, L13V, and aurein 2.2
were the most effective at inserting into POPC/POPG bila-
yers, with threshold P/L ratios of 1:80–1:120. L13A, on
the other hand, was slightly less effective, and aurein 2.3,
with an Ile at position 13, was the least effective. Insertion
of all the peptides was accompanied by perturbations
consistent with toroidal pore formation, as seen in the 31P
NMR results here and the results previously reported for
aurein 2.2 and 2.3 (33). At low peptide concentrations, the
extent of membrane disruption, as indicated by the 31P
signals from unoriented headgroups, was similar in the pres-
ence of all three mutants. Of interest, however, at high
peptide concentrations (1:15 P/L ratio) L13V significantly
perturbed the membrane bilayers. Perhaps the high helical
content of L13V as seen from the CD data could account
for this observation.Biophysical Journal 99(9) 2926–2935The results obtained with the L13A, L13F, and L13V
mutants demonstrate that overall it is difficult to clearly
correlate subtle changes in sequence with subtle changes
in structure and membrane interaction. What the data
suggest in broad terms, however, is that the structure and
membrane interaction of the aurein peptides correlate
reasonably well with theMIC andmembrane depolarization.
Indeed, aurein 2.2 and L13V, which were the most helical
and effective at inserting into and perturbing POPC/POPG
bilayers, were effective antimicrobial peptides and depolar-
ized bacterial membranes well. On the other hand, aurein
2.3, which did not readily insert into POPC/POPG bilayers
(as seen from the OCD data), also did not depolarize
membranes well (33) and was not as good an antimicrobial
peptide as aurein 2.2 (32). Of course, comparing data ob-
tained from a bacterial membrane model system with those
obtained from bacteria is fraught with danger, but if we are to
gain insight into how the aurein peptides function, models
are a necessary evil. As presented in a recently submitted
manuscript (J. T. J. Cheng, J. D. Hale, J. Kindrachuk,
H. Jessen, M. Elliott, R. E. W. Hancock, and S. K. Straus),
we explored the choice of bacterial model membranes by
Mutant Aurein 2.2 Structure/Function 2933investigating the structure and membrane interaction of aur-
ein 2.2, aurein 2.3, and the mutants studied here in POPE/
POPG (1:1) and cardiolipin/POPG (1:1) membranes.
Since the residue-13 substitutions studied here did not
significantly influence the structure or peptide-membrane
interactions, we also investigated the more dramatic effect
of truncating the C-terminus of aurein 2.2. To this end, we
examined two C-terminally truncated mutants: one with
the last three residues in aurein 2.2 removed (loss of
G14S15L16) and the other with the last six residues in aurein
2.2 removed (loss of G11A12L13G14S15L16). Both of these
deletion mutants retained a predominantly a-helical struc-
ture, as seen in the solution CD results (Fig. 1). However,
aurein 2.2-D6 showed a much lower helical content at all
P/L ratios. The extensively truncated aurein 2.2-D6 may
be too short to form an ordered conformation, as observed
for the bioactive gastrin-17 analogs (76) and the (KIGAKI)n
peptide (77). A CD study of magainin-2 also demonstrated
that a minimum of 12 residues (with a helical length of
24 ~ 34 A˚) is required for antimicrobial activity (78).
Both the decreased helical content and the increased random
coil content would contribute to the inability of the peptide
to perturb lipid membranes to full capacity (77).
Previous studies on cationic antimicrobial peptides have
demonstrated that positively charged residues (e.g., Lys
and Arg) are important for activity, whereas negatively
charged or neutral amino acid (e.g., Asp and Ser) are refrac-
tory (79). Aurein 2.2 has two Lys residues located at
position 7 and 8, and a Ser at position 15, resulting in
a net þ2 charge (Table S1). Truncating the first three
C-terminal residues removed Ser-15 but did not have an
effect on the net charge (Table S1). Our MIC and OCD
results showed that this truncation did not have a consider-
able effect on the antimicrobial activity or the insertion
profile of the peptide (aurein 2.2-D3). This suggests that
the peptide segment G14S15L16 is not necessary for antimi-
crobial activity. Indeed, the activity of aurein 2.2-D3 is
identical to that of its parent, aurein 2.2. Removal of a larger
segment of aurein 2.2, on the other hand, had a significant
effect on the antimicrobial activity and insertion profile of
the peptide, as seen from our MIC and OCD results. This
implies that the peptide segment G11A12L13 is crucial for
antimicrobial activity and membrane interactions. The
GAL segment may be needed as a longer C-terminal hydro-
phobic segment for better peptide-membrane interactions,
or it may provide more effective hydrophobic side-chain
packing, as proposed for PMAP-23 (a cathelicidin) (80)
and aurein 1.2 (81). It is also possible, however, that aurein
2.2-D6 is simply of insufficient peptide length (~15 A˚) to
span the thicker POPC/POPG bilayers (~39 A˚) (82), as
was previously observed for the short-chain peptide ampul-
losporin A (83). This would explain why very high concen-
trations of aurein 2.2-D6 are needed for insertion to occur at
all. Once inserted, both aurein 2.2-D3 and aurein 2.2-D6
perturb the lipids by forming (distorted) toroidal pores.Overall, the results presented here demonstrate the impor-
tance of residue 13 for the structure and function of aurein
2.2. Removal of L13 has a dramatic effect on structure,
membrane interaction, toroidal pore formation, MIC, and
membrane depolarization. This clearly indicates that the
presence of residue 13 is critical for activity. The exact
nature of residue 13, however, is less important as long as
it is a hydrophobic residue. Indeed, substitution of L13 in
aurein 2.2 to Ala, Phe, Val, or Ile (as in aurein 2.3) results
in antimicrobial peptides that display similar activities.
Presumably, nature has a built-in tolerance to the exact
type of amino acid residue at a given position in the cationic
antimicrobial peptide, as long as its essential character (e.g.,
hydrophobicity (84)) is preserved. The fact that the L13
mutants have similar activities but display different extents
of membrane depolarization further suggests that there is
a tolerance in the exact mechanism that cationic antimicro-
bial peptides use to kill bacteria (85).SUPPORTING MATERIAL
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